Markita Landry and Stephan Lammel have won an inaugural Parkinson’s Therapeutics Award from UC Berkeley’s Molecular Therapeutics Initiative (MTI) for their collaborative research project titled “Regeneration of Dopaminergic Axons in Parkinson’s Disease”. With these awards, MTI aims to transform high-impact academic discoveries into therapeutic leads. The three winning projects for 2026 are all aimed at slowing or halting the progression of Parkinson’s disease, rather than simply masking symptoms.
Landry, an associate professor of neuroscience and chemical & biomolecular engineering, and Lammel, an associate professor of neuroscience, will receive $90,000 in funding for their research project, as well as priority access to MTI’s drug discovery resources to help speed the development of new therapies.
